|
|
|
Volumn 13, Issue 3, 2010, Pages 166-168
|
|
Phosphodiesterase targets for cognitive dysfunction and schizophrenia - A New York academy of sciences meeting
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [4 [1 METHYL 4 (4 PYRIDINYL) 3 PYRAZOLYL]PHENOXYMETHYL]QUINOLINE;
DOPAMINE 1 RECEPTOR STIMULATING AGENT;
NEUROLEPTIC AGENT;
NOOTROPIC AGENT;
PAPAVERINE;
PF 4181366;
PHOSPHODIESTERASE IB INHIBITOR;
PHOSPHODIESTERASE INHIBITOR;
PHOSPHODIESTERASE IX INHIBITOR;
PHOSPHODIESTERASE X INHIBITOR;
ROLIPRAM;
TP 10;
UNCLASSIFIED DRUG;
WEB 3;
CATALEPSY;
COGNITIVE DEFECT;
CONFERENCE PAPER;
DRUG EFFECT;
HUMAN;
MEMORY;
NONHUMAN;
PREPULSE INHIBITION;
SCHIZOPHRENIA;
SOCIAL BEHAVIOR;
STARTLE REFLEX;
UNITED STATES;
ANIMALS;
COGNITION;
COGNITION DISORDERS;
CYCLIC AMP;
DRUG DISCOVERY;
DRUG INDUSTRY;
DRUGS, INVESTIGATIONAL;
HUMANS;
PHOSPHODIESTERASE INHIBITORS;
PHOSPHORIC DIESTER HYDROLASES;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
|
|
EID: 77749309302
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (22)
|
|
References (0)
|
